Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Feb 12, 2020 11:19am
72 Views
Post# 30680645

RE:Ryplazim 2021

RE:Ryplazim 2021Not sure who's post you are referring to.

I am referring to Page 11 of the February 2020 corporate presenttation.  The page is headed "Anticipated Milestones:  2021 & beyond".  Not 2020, but 2021.

The first item is "Anticipated Ryplazim FDA approval and launch".

Click Here for link to presentation


Newcamo, Pando, realstocky won't provide a link to their data.  Either made up or so old it is irrelevant.

Provide a live link boys.  You cant, LOL  First, you dont know what a live link is and second, your data doesnt exist.

Grugar wrote: Where did you get this info ? 


<< Previous
Bullboard Posts
Next >>